Advagraf



Indications and Reactions:

Role Indications Reactions
Primary
Renal Transplant 24.0%
Immunosuppression 18.1%
Product Used For Unknown Indication 14.0%
Prophylaxis Against Transplant Rejection 9.9%
Hypertension 9.4%
Infection Prophylaxis 3.5%
Gastrooesophageal Reflux Disease 2.9%
Liver Transplant 2.9%
Anaemia 2.3%
Antiviral Prophylaxis 2.3%
Dyslipidaemia 1.8%
Antifungal Prophylaxis 1.2%
Anxiety 1.2%
Gastrooesophageal Reflux Prophylaxis 1.2%
Hypokalaemia 1.2%
Hypothyroidism 1.2%
Vitamin D Deficiency 1.2%
Anaemia Prophylaxis 0.6%
Asthma 0.6%
Benign Prostatic Hyperplasia 0.6%
Medication Error 34.0%
Transplant Rejection 8.0%
Death 6.0%
Wrong Drug Administered 6.0%
Blood Creatinine Abnormal 4.0%
Drug Level Fluctuating 4.0%
Intentional Drug Misuse 4.0%
Renal Failure Acute 4.0%
Treatment Noncompliance 4.0%
Tremor 4.0%
Urinary Tract Infection 4.0%
Ankle Fracture 2.0%
Blood Count Abnormal 2.0%
Cerebral Vasoconstriction 2.0%
Complications Of Transplanted Kidney 2.0%
Crohn's Disease 2.0%
Drug Administration Error 2.0%
Drug Intolerance 2.0%
Fall 2.0%
Gastrointestinal Disorder 2.0%
Secondary
Renal Transplant 18.8%
Prophylaxis 18.5%
Pain Prophylaxis 14.8%
Drug Use For Unknown Indication 11.5%
Product Used For Unknown Indication 7.3%
Prophylaxis Against Transplant Rejection 6.0%
Constipation Prophylaxis 5.9%
Thrombosis Prophylaxis 3.2%
Immunosuppression 3.1%
Liver Transplant 2.8%
Hypertension 2.2%
Systemic Lupus Erythematosus 1.3%
Diabetes Mellitus 1.2%
Cholestasis 0.6%
Muscular Weakness 0.6%
Nephrotic Syndrome 0.6%
Osteoporosis Prophylaxis 0.6%
Infection Prophylaxis 0.5%
Abortion Induced 0.4%
Transplant Rejection 0.4%
Urinary Tract Infection 18.3%
Transplant Rejection 17.6%
Viral Infection 13.0%
Meningitis Enterococcal 6.9%
Intestinal Ulcer 5.3%
Progressive Multifocal Leukoencephalopathy 4.6%
Pyrexia 4.6%
Renal Failure Acute 4.6%
Intentional Drug Misuse 3.1%
Medication Error 3.1%
Pyelonephritis 3.1%
Thrombotic Microangiopathy 2.3%
Ventricular Septal Defect 2.3%
Vomiting 2.3%
Agranulocytosis 1.5%
Incorrect Dose Administered 1.5%
Polyneuropathy 1.5%
Pulmonary Embolism 1.5%
Thrombocytopenia 1.5%
Urosepsis 1.5%
Concomitant
Product Used For Unknown Indication 35.9%
Renal Transplant 12.8%
Immunosuppression 8.4%
Liver Transplant 6.7%
Prophylaxis Against Transplant Rejection 5.0%
Hypertension 4.7%
Prophylaxis 4.5%
Hepatitis C 3.3%
Mri 2.2%
Nocardiosis 2.2%
Nuclear Magnetic Resonance Imaging 2.2%
Diabetes Mellitus 1.9%
Atrial Fibrillation 1.7%
Colorectal Cancer Metastatic 1.4%
Pain 1.4%
Anaemia 1.1%
Imaging Procedure 1.1%
Lung Transplant 1.1%
Osteoporosis 1.1%
Pneumonia 1.1%
Weight Decreased 10.2%
Vomiting 8.2%
Organising Pneumonia 6.1%
Renal Failure 6.1%
Swollen Tongue 6.1%
Thrombocytopenia 6.1%
Cholestasis 4.1%
Death 4.1%
Graft Versus Host Disease 4.1%
Hepatocellular Injury 4.1%
Infection 4.1%
Leukopenia 4.1%
Meningitis Enterococcal 4.1%
Neutropenia 4.1%
Prostatic Adenoma 4.1%
Pruritus 4.1%
Pulmonary Oedema 4.1%
Renal Failure Acute 4.1%
Skin Tightness 4.1%
Tongue Oedema 4.1%
Interacting
Hypertension 21.3%
Renal Failure Chronic 17.0%
Renal Transplant 14.9%
Hepatitis C 12.8%
Liver Transplant 12.8%
Antiretroviral Therapy 8.5%
Gastritis 4.3%
Oedema Peripheral 4.3%
Gout 2.1%
Pain 2.1%
Immunosuppressant Drug Level Increased 25.0%
Renal Failure Acute 25.0%
Thrombocytopenia 25.0%
Tremor 25.0%